Table 1.
Clinicopathological Characteristics of Patients.
| Variables | Patients with SCCE (n = 52) |
|---|---|
| Gender | |
| Male | 38 (73.1%) |
| Female | 14 (26.9%) |
| Age | |
| ≤60 | 29 (55.8%) |
| >60 | 23 (44.2%) |
| BMI, mean (SD) | 22.3 (3.7) |
| Chronic diseases | |
| No | 44 (84.6%) |
| Yes | 8 (15.4%) |
| Preoperative albumin level | |
| Low | 7 (13.5%) |
| Normal | 45 (86.5%) |
| Surgical approach | |
| Sweet | 35 (63.7%) |
| Ivor Lewis/McKeown | 17 (32.7%) |
| Location | |
| Upper/Middle | 36 (69.2%) |
| Lower/EGJ | 16 (30.8%) |
| Pathological features | |
| Pure SCCE | 35 (76.3%) |
| Combined SCCE | 17 (32.7%) |
| Tumor length | |
| <5cm | 46 (88.5%) |
| ≥5cm | 6 (11.5%) |
| Radical resection | |
| R0 | 47 (90.4%) |
| R1 | 5 (9.6%) |
| pT category | |
| T1 | 7 (13.5%) |
| T2 | 19 (36.5%) |
| T3 | 22 (42.3%) |
| T4 | 4 (7.7%) |
| pN category | |
| N0 | 20 (38.5%) |
| N1 | 10 (19.2%) |
| N2 | 10 (19.2%) |
| N3 | 12 (23.1%) |
| TNM stage | |
| I | 8 (15.4%) |
| II | 13 (25.0%) |
| III | 18 (34.6%) |
| IV | 13 (25.0%) |
| Adjuvant therapy | |
| No adjuvant therapy | 25 (48.1%) |
| Chemotherapy alone | 20 (38.5%) |
| Radiotherapy alone | 4 (7.7%) |
| Radiochemotherapy | 3 (5.8%) |
Abbreviations: BMI, body mass index; SCCE, small cell carcinoma of esophagus; EGJ, esophagogastric junction; SD, standard deviation.